4
Changes in Ownership
Fulcrum Therapeutics, Inc. Filed Acc 0000950170-25-068038
Principal Accounting Officer sold 498 shares at $5.06 ($2,520)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Tourangeau Greg Principal Accounting Officer | 2025-05-08 | Sale | −498 | $5.06 | $2,520 | 14,062 | D |
| Open-market sales · 498 sh · avg $5.06 · $2,520 | |||||||
Loading xslF345X05/ownership.xml…